HALO
(NASDAQ)Halozyme Therapeutics, Inc.
---- (--)
Loading... - Market loading
Halozyme Therapeutics (HALO) Stock Price & Financial Analysis
Halozyme Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Day's Range$77.55 - $81.19
52-Week High$82.22
52-Week Low$47.50
Open$77.83
Volume1.74M
Average Volume (3M)1.74M
Market Cap9.72B
Shares Outstanding122.33M
P/E Ratio (TTM)16.32
Forward P/E10.76
Price to Sales (P/S)7.82
Price to Book (P/B)19.28
EV/EBITDA12.82
Revenue (TTM)1.24B
Net Income (TTM)595.49M
Free Cash Flow (TTM)602.40M
EPS (TTM)$4.87
Profit Margin47.91%
Operating Margin59.33%
Return on Equity (ROE)118.17%
Debt to Equity3.00
50-Day MA$70.53
200-Day MA$65.53
52-Week Change35.54%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Day's Range$77.55 - $81.19
52-Week High$82.22
52-Week Low$47.50
Open$77.83
Volume1.74M
Average Volume (3M)1.74M
Market Cap9.72B
Shares Outstanding122.33M
P/E Ratio (TTM)16.32
Forward P/E10.76
Price to Sales (P/S)7.82
Price to Book (P/B)19.28
EV/EBITDA12.82
Revenue (TTM)1.24B
Net Income (TTM)595.49M
Free Cash Flow (TTM)602.40M
EPS (TTM)$4.87
Profit Margin47.91%
Operating Margin59.33%
Return on Equity (ROE)118.17%
Debt to Equity3.00
50-Day MA$70.53
200-Day MA$65.53
52-Week Change35.54%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%
Latest News
Recent news and articles about HALO